Levon is from Artsakh and has been battling acute myeloblastic leukemia since August 2023.

On June 4, 2024, he underwent a complex stem cell transplant. However, shortly after the procedure, Levon faced a new challenge — a severe post-transplant complication known as GVHD (Graft-Versus-Host Disease). This occurs when the donor’s immune cells attack the recipient’s body — in Levon’s case, damaging his liver and skin. Without ongoing targeted therapy, this condition can become fatal.

Levon must take two life-saving medications daily —
• Ruxolitinib, a targeted therapy that helps control GVHD and reduce inflammation,
• Belumosudil, used to treat skin GVHD and prevent further organ damage and spread of the disease.

These medications are essential for Levon’s recovery but come with a heavy financial burden his family cannot manage alone.

Your support — no matter the size — can save his life.
Together, we can help Levon reclaim his health and continue his fight for life.